| Company Name: |
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd
|
| Tel: |
021-59167510 18117107507 |
| Email: |
vip@med-life.cn |
| Products Intro: |
Product Name:P11149
CAS:164724-79-2
Purity:>=99% Package:10mg;50mg;100mg;5mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:P11149
CAS:164724-79-2
Package:25mg/RMB 12800;100mg/RMB 21500;50mg/RMB 16800
|
P11149 manufacturers
- P11149
-
- $1310.00 / 25mg
-
2024-10-28
- CAS:164724-79-2
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | P11149 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 100 mg/mL (211.86 mM; Need ultrasonic) | | form | Solid | | color | White to off-white |
| | P11149 Usage And Synthesis |
| Biological Activity | P11149 is a competitive, BBB-penetarated weakly, orally active and selective inhibitor of AChE. P11149 exhibits an IC50 of 1.3 μM for rat BChE/AChE. P11149, a Galanthamine derivative, demonstrates central cholinergic activity, behavioral efficacy and safety. P11149 is used in the study for Alzheimer’s disease[1].
P11149 is a GAL analog that is rapidly hydrolyzed in vivo to yield the potent AChE inhibitor, 6-DMG[1].P11149 exhibits greater s.c. bioavailability than p.o. [1].Oral P11149 in mice produces Sal, Lac and tremors at doses similar to those in rats, whereas 6-DMG, P1 1012 and GAL produces Sal and Lac at doses lower than those in rats[1].P11149 exhibits T1/2(el) of 2.4 h and Cmax of 585 ng/mL in rat plasma[1]. | | References | [1]. G M Bores, et al. Pharmacological evaluation of novel Alzheimer’s disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. J Pharmacol Exp Ther. 1996 May;277(2):728-38. |
| | P11149 Preparation Products And Raw materials |
|